Sourav Ganguly becomes the brand Ambassador for Piramal's antacid Polycrol Medical Dialogues Bureau27 Feb 2020 8:32 AM GMTAvailable in a mint flavour, Polycrol is one of India's leading liquid antacid brands, and is amongst the top 3 in Eastern India, including West...
Piramal Enterprises plans to raise upto Rs 1000 crore via NCDs Medical Dialogues Bureau28 Oct 2019 4:15 AM GMTThe administrative committee of the board approved the issue of secured NCDs on private placement basis up to Rs 500 crore with an option to retain...
Piramal Enterprises Q1 profit rises 21 percent to Rs 461 crore Medical Dialogues Bureau31 July 2019 3:30 AM GMTPiramal Enterprises said its total loan book grew 20 per cent year-on-year to Rs 56,605 crore. The housing finance loan book, which constitutes 11 per...
Piramal cuts short-term borrowings, reduces dependence on CPs as NBFC crisis lingers Medical Dialogues Bureau12 July 2019 3:45 AM GMTPiramal Enterprises chairman Ajay Piramal in his address to the shareholders in the FY19 annual report said the company continues to build resilience...
Piramal Pharma invests over Rs 69 crore to expand its API capability Medical Dialogues Bureau21 Jun 2019 4:30 AM GMTThe new wing at the Riverview site is dedicated to the production of HPAPIs with low occupational exposure levels (OELs), Piramal Pharma Solutions...
Panacea Biotec Bail out: Piramal, Bain offer Rs 992 crore deal Garima9 April 2019 4:15 AM GMTMUMBAI: India Resurgence Fund (IRF) led by Piramal Enterprises and Bain Capital Credit recently said it will invest Rs 992 crore in New Delhi-based...
Piramal Enterprises plans to raise up to Rs 1,000 crore via non-convertible debentures Medical Dialogues Bureau22 Nov 2018 11:07 AM GMTNEW DELHI: Piramal Enterprises on Wednesday said it plans to raise up to Rs 1,000 crore through issue of secured non-convertible debentures (NCDs) on...
FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart Medical Dialogues Bureau18 Sep 2018 7:17 AM GMTSupreme court lifted the ban on the sale of Piramal Healthcare's Saridon, GlaxoSmithKline's Piriton, Juggat Pharma's Dart and another drug, banned...
Piramal acquires Digeplex from Shreya Lifesciences Ruby Khatun Khatun1 Dec 2017 5:30 AM GMTMUMBAI: Piramal Enterprises acquired the Digeplex and the associated brands from Shreya Lifesciences for an undisclosed sum to expand its consumer...
Piramal group expands healthcare project ASARA Ruby Khatun Khatun10 Nov 2017 5:01 AM GMTVishakhapatnam: Piramal Swasthya, an initiative under the aegis of Piramal Foundation (the philanthropic arm of the Piramal Group), announced the...